- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVAX
Recent news which mentions NVAX
Why Is Humanigen (HGEN) Stock Plunging 79% Today?
July 13, 2022
From InvestorPlace
Novavax (NVAX) Stock Pops Ahead of FDA Approval
July 13, 2022
From InvestorPlace
Why Novavax Stock Shot Higher Today
July 12, 2022
From Motley Fool
3 Cheap Stocks To Buy Now
July 12, 2022
From Motley Fool
Novavax Stock: Bear vs. Bull
July 12, 2022
From Motley Fool
Novavax Stock Is Sizzling Hot Once Again -- Time to Buy?
July 12, 2022
Tickers
NVAX
From Motley Fool
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
July 12, 2022
From Benzinga
Which Coronavirus Stock Could Fetch Higher Returns?
July 11, 2022
From InvestorPlace
Why Are Chip Stocks NVDA, AMD, INTC Down Today?
July 11, 2022
From InvestorPlace
What Is Going on With Novavax (NVAX) Stock Today?
July 11, 2022
From InvestorPlace
From MarketWatch
US Government Signs COVID-19 Vaccine Pact With Novavax, With FDA Decision Still Pending
July 11, 2022
From Benzinga
3 Top Healthcare Stocks to Buy for July
July 07, 2022
From Motley Fool
Why Novavax Stock Lagged the Market on Wednesday
July 06, 2022
From Motley Fool
This May Be Pfizer's Key to Long-Term Vaccine Dominance
July 06, 2022
From Motley Fool
COVID hospitalizations dip for first time since mid-April, but daily deaths reach 2 1/2-month high
July 05, 2022
From MarketWatch
Why Is Novavax (NVAX) Stock Rallying Today?
July 05, 2022
From InvestorPlace
Why Is Novavax (NVAX) Stock Up 10% Today?
July 01, 2022
From InvestorPlace
Tickers
NVAX
From Motley Fool
The U.S. bets billions of dollars on better COVID-19 boosters as it prepares for a spike in COVID-19 cases next winter
July 01, 2022
From MarketWatch
Could This Send Moderna's Stock Soaring Back to $400?
June 30, 2022
From Motley Fool
2 Risky Stocks That Could Continue Falling This Year
June 30, 2022
From Motley Fool
Novavax is part of the FDA’s COVID-19 booster debate, but its vaccine still hasn’t been authorized
June 29, 2022
From MarketWatch
From Benzinga
Novavax Stock Is in Prime Position For Speculation
June 29, 2022
From InvestorPlace
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.